doi:10.1056/NEJMoa1509225 299
Nine manufacturers Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi agreed to reduce prices on drugs that treat type two diabetes, rheumatoid arthritis, multiple sclerosis, asthma, COPD, hepatitis B and C, HIV, and certain cancers, providing every State Medicaid program access to MFN drug prices
So tirzepatide has a slightly higher reporting rate, but both are in the low single digits
[13] [14] A meaningful reduction in fat mass can therefore lower oestrogen levels, thinning the uterine lining and reducing menstrual flow or preventing menstruation entirely
The Misleading 'Shortage' Claim Some clinics claim their compounded semaglutide products are legal due to a current shortage of Ozempic and Wegovy